302 related articles for article (PubMed ID: 17371997)
1. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets.
Estefanía E; Flores R; Gómez-Lozano N; Aguilar H; López-Botet M; Vilches C
J Immunol; 2007 Apr; 178(7):4402-10. PubMed ID: 17371997
[TBL] [Abstract][Full Text] [Related]
2. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
Yusa S; Catina TL; Campbell KS
J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
[TBL] [Abstract][Full Text] [Related]
3. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
4. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
5. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
6. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
[TBL] [Abstract][Full Text] [Related]
7. KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression.
Cisneros E; Moraru M; Gómez-Lozano N; López-Botet M; Vilches C
Front Immunol; 2012; 3():289. PubMed ID: 23060877
[TBL] [Abstract][Full Text] [Related]
8. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
Faure M; Long EO
J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
[TBL] [Abstract][Full Text] [Related]
10. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.
Binstadt BA; Brumbaugh KM; Dick CJ; Scharenberg AM; Williams BL; Colonna M; Lanier LL; Kinet JP; Abraham RT; Leibson PJ
Immunity; 1996 Dec; 5(6):629-38. PubMed ID: 8986721
[TBL] [Abstract][Full Text] [Related]
11. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.
Vilches C; Rajalingam R; Uhrberg M; Gardiner CM; Young NT; Parham P
J Immunol; 2000 Jun; 164(11):5797-804. PubMed ID: 10820258
[TBL] [Abstract][Full Text] [Related]
12. KIR2DL4 (CD158d) genotype influences expression and function in NK cells.
Goodridge JP; Witt CS; Christiansen FT; Warren HS
J Immunol; 2003 Aug; 171(4):1768-74. PubMed ID: 12902476
[TBL] [Abstract][Full Text] [Related]
13. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
Vyas YM; Maniar H; Lyddane CE; Sadelain M; Dupont B
J Immunol; 2004 Aug; 173(3):1571-8. PubMed ID: 15265884
[TBL] [Abstract][Full Text] [Related]
14. Allelic Polymorphism Determines Surface Expression or Intracellular Retention of the Human NK Cell Receptor KIR2DL5A (CD158f).
Cisneros E; Estefanía E; Vilches C
Front Immunol; 2016; 7():698. PubMed ID: 28144240
[TBL] [Abstract][Full Text] [Related]
15. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.
Colonna M; Navarro F; Bellón T; Llano M; García P; Samaridis J; Angman L; Cella M; López-Botet M
J Exp Med; 1997 Dec; 186(11):1809-18. PubMed ID: 9382880
[TBL] [Abstract][Full Text] [Related]
16. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
Colonna M; Nakajima H; Navarro F; López-Botet M
J Leukoc Biol; 1999 Sep; 66(3):375-81. PubMed ID: 10496306
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the natural killer cell receptor repertoire.
Raulet DH; Vance RE; McMahon CW
Annu Rev Immunol; 2001; 19():291-330. PubMed ID: 11244039
[TBL] [Abstract][Full Text] [Related]
18. Homogenous expression of killer cell immunoglobulin-like receptors (KIR) on polyclonal natural killer cells detected by a monoclonal antibody to KIR2D.
Watzl C; Peterson M; Long EO
Tissue Antigens; 2000 Sep; 56(3):240-7. PubMed ID: 11034560
[TBL] [Abstract][Full Text] [Related]
19. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
20. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
